Key result
Left ventricular assist device decompression of dilated left ventricles in infants and children led to recovery and long-term survival without transplantation in 73% of patients.
Why the study?
Does LVAD decompression promote myocardial recovery and survival without transplantation in infants and children with dilated cardiomyopathy?
Observational (n=11)
Does LVAD decompression promote myocardial recovery and survival without transplantation in infants and children with dilated cardiomyopathy?
Answers are grounded in this paper and cite their sources.
LVAD decompression in infants and children with dilated cardiomyopathy can lead to myocardial recovery and long-term survival without the need for heart transplantation.
Most infants and children implanted with left ventricular assist devices (LVADs) are bridged to cardiac transplantation. Prioritizing recovery may decrease this trend. Patients were treated with LVAD ventricular decompression, medical heart failure therapy, and bolus therapy with a beta-agonist before weaning trials. Devices were removed if adequate function was observed. Eleven patients with a mean age of 1.7 years presented for LVAD implantation. The mean Z score for left ventricular end diastolic diameter (LVEDD) was +5.5 (+1.6 to +7.3), and the mean fractional shortening was 9% (5%-14%). They were on maximal medical therapy and inotropic support. Duration of device support ranged from 6 to 22 days (mean: 13 days). There were three deaths, one from preimplant anoxic brain damage and two from thromboembolism. Eight patients (73%) recovered, were explanted, and are alive 0.6-6 years with hearts that have a mean Z score for LVEDD of 1.0 (0.09-3.7) and fractional shortening of 23%-36%. Left ventricular assist device decompression of dilated left ventricles in infants and children led to long-term survival in 73%. Ventricular size was significantly reduced and contractility significantly increased. None of these patients required transplantation.
No takes yet. Share an insight, caveat, or question.
Zimmerman et al. (2010) conducted an observational in Dilated cardiomyopathies (n=11). Left ventricular assist device (LVAD) decompression, medical heart failure therapy, and beta-agonist bolus was evaluated on Recovery, explantation, and long-term survival. Left ventricular assist device decompression of dilated left ventricles in infants and children led to recovery and long-term survival without transplantation in 73% of patients.
Synapse has enriched 10 related papers. Consider them for comparative context: